Analysis of the dynamics of clinical indicators in patients with allergic rhinitis with sensitization to pollen and household allergens using combined allergen-specific immunotherapy

S.V. Biletska; E.M. Dytyatkovska; M.A.  Nikolaychuk

doi:10.26641/2307-0404.2021.4.248161

Автор(и)

S.V. Biletska Medical Center “Unimed”, Mlodej Polski str., 7, Krakow, 30-131, Польща
E.M. Dytyatkovska Dnipro State Medical University, V. Vernadsky str., 9, Dnipro, 49044, Україна https://orcid.org/0000-0001-9007-8634
M.A. Nikolaychuk Dnipro State Medical University, V. Vernadsky str., 9, Dnipro, 49044, Україна

DOI:

https://doi.org/10.26641/2307-0404.2021.4.248161

Ключові слова:

allergic rhinitis, rhinoconjunctivitis, combined allergen-specific immunotherapy, clinical effect

Анотація

The aim of this study was to evaluate the clinical efficacy of combined allergen-specific immunotherapy (ASIT) in patients with allergic rhinitis (AR) with combined sensitization to pollen and household allergens. To achieve this goal, 49 patients with AR of working age were examined – 35.5±1.5 years with clinical manifestations of seasonal rhinoconjunctival syndrome with a long period of 9.2±1.1 years, among which there were 25 (51.0%) males and 24 (49%) females. All patients were divided into 2 homogeneous groups by age, sex, duration of the disease, the average number of etiologically significant allergens: the main one – 31 patients who received combined ASIT with solutions of pollen and household allergens and a comparison group – 18 patients for whom only pollen allergens were used. Allergological examination included anamnesis, skin tests with pollen allergens (wormwood, ragweed, quinoa, corn, etc.) and household (house dust, mites, epidermal agents) and / or molecular research methods using the ALEX technology. The quantitative integral assessment of the intensity of AR clinical symptoms was calculated as a total score for the main symptoms. The maximum score for the severity of nasal symptoms – 12, eye - 6, total – 18. The results obtained and their analysis indicate that under the influence of ASIT pollen and household allergens in patients there is a significant and reliable decrease in the intensity of clinical manifestations of seasonal rhinoconjunctive syndrome: nasal manifestations – by 52,2%, conjunctival – by 60%, integral – by 54.3% and an increase of 2.2 times in the percentage of patients in the main group with the disappearance or minimization of clinical symptoms of the disease after treatment compared with patients from the comparison group, which convincingly proves and confirms high efficiency of the selected type of therapy in patients with AR in combination with sensitization to pollen and household allergens.

Посилання

Antomonov MYu. [Mathematical processing and analysis of biomedical data]. Kyiv: Medinform; 2018. p. 579. Russian.

Hohunskaia IV, Naumova OA, Kholodenko TYu. [New directions in the diagnosis and treatment of allergic diseases of the upper respiratory tract]. Ukrainskyi pulmonolohichnyi zhurnal. 2016;2:66-67. Russian.

Dytyatkovska EM. [Dynamics of cytokines in patients with hay fever under the influence of ASIT depending on the spectrum of sensitization]. Imunolohiia ta alerholohiia: nauka i praktyka. 2011;3:80-83. Ukrainian.

Dytyatkovska EM, Hohunska IV, Dytiatkovskyi VO. [Allergic rhinitis, epidemiology, pathogenesis, diagnosis, treatment]. Kyiv: Vistka; 2014. p. 208. Ukrainian.

Pukhlyk BM. [Pollinosis: a monograph]. Vinnytsia; 2017 p. 60. Ukrainian.

Pukhlyk BM., Bobelo OL, Dziubenko SP. [House dust mites are the most important allergens in the human environment]. Klinichna imunologhiia. Alerholohiia. Infektolohiia. 2018;108(3):22-26. Russian.

Bousquet J, Khaltaev N, Cruz AA, Denburg J, et al. Allergic Rhinitis and its impacts on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008 Apr;63:8-160.

doi: https://doi.org/10.1111/j.1398-9995.2007.01620.x

Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017 Oct;140(4):950-58.

Dytyatkovska E, Gashynova K, Panov V. Patters of molecular sensitization in adults in Dnipro region (Ukraine). Allergy. 2019;74:831-2.

Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P, et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases. Allergy J Int. 2014;23(8):282-319.

doi: https://doi.org/10.1007/s40629-014-0032-2

Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, et al. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol. 2016 Feb:137(2):358-68. doi: https://doi.org/10.1016/j.jaci.2015.12.1300

Pfaar O, Demoly P, Gerth R, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014;69(7):854-67. doi: https://doi.org/10.1111/all.12383